Alzheimer's disease & dementia

ADT use not linked to dementia in prostate cancer

(HealthDay)—For men with prostate cancer, use of androgen deprivation therapy (ADT) seems not to be associated with dementia, according to a study published online Nov. 21 in the Journal of Clinical Oncology.

Oncology & Cancer

Common prostate cancer treatment linked to later dementia

A new retrospective study of patient medical records suggests that men with prostate cancer who are treated with testosterone-lowering drugs are twice as likely to develop dementia within five years as prostate cancer patients ...

Oncology & Cancer

Decision regret uncommon after radical prostatectomy, IMRT

(HealthDay)—For patients with prostate cancer treated with radical prostatectomy (RP) and post-prostatectomy image-guided intensity-modulated radiotherapy (IG-IMRT), decision regret (DR) is uncommon and occurs more often ...

Oncology & Cancer

Prostate cancer diagnoses down from 2011 to 2013

(HealthDay)—From 2011 to 2013 there was a decrease in prostate cancer (PC) diagnoses, especially for younger men and low-risk disease, according to a research letter published online June 23 in JAMA Oncology.

Oncology & Cancer

ADT plus radiotherapy ups survival in metastatic prostate CA

(HealthDay)—For men with metastatic prostate cancer (mPCa), overall survival (OS) is improved for those treated with androgen deprivation therapy (ADT) and prostate radiotherapy (RT), compared with ADT alone, according ...

page 6 from 11